Study findings on rectal cancer are outlined in reports from Maria Sklodowska-Curie Memorial Cancer Center, Department of Radiotherapy

Researchers detail in 'Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation,' new data in rectal cancer. In this recent report, researchers in Warsaw, Poland conducted a study "To explore the utility of tumor regression grading (TRG, the amount of residual tumor cells in relation to extension of fibrosis) after chemoradiation of rectal cancer. Of 131 patients who received preoperative chemoradiation in the frame of the randomized trial, pathological complete response (pCR, TRG0), good regression (TRG1), moderate regression (TRG2), and poor regression (TRG3) were recorded in 17%, 31%, 31%, and 22% of patients, respectively."

...

Want to see the full article?

• Purchase this article for only $3.00